Physician profile
Dorwin T Moore
NPI 1396706248
$915.95
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $177 · 2021: $380 · 2022: $182 · 2023: $73.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $73.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $73.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $158.47 | 2019-2021 | |
| Aspira Women'S Health INC | $125.24 | 2021-2023 | Ova1 |
| Exeltis, USA INC. | $107.31 | 2020-2022 | |
| Hologic Sales and Service, LLC | $86.16 | 2020-2023 | Myosure Tissue Removal Device, Fluent Fluid Management System, Acessa Provu System |
| Daiichi Sankyo INC. | $85.23 | 2020-2021 | |
| Organon LLC | $45.20 | 2021-2023 | Nexplanon |
| Therapeuticsmd, INC. | $44.14 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $42.14 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $34.32 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.48 | 2022 | |
| Evofem Biosciences, INC. | $31.38 | 2021 | |
| Agile Therapeutics, INC. | $30.51 | 2021 | |
| Smith+Nephew, INC. | $25.10 | 2022 | |
| Sumitomo Pharma America, INC. | $21.33 | 2023 | Myfembree |
| Amag Pharmaceuticals, INC. | $12.81 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $11.87 | 2021 | |
| Mylan Pharmaceuticals INC. | $11.78 | 2020 | |
| Myovant Sciences INC. | $11.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dorwin Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.